CD28 and neoplasm: In vitro, this human PD1:CD28 was shown to respond to programmed death-ligand 1 (PD-L1)-expressing tumor cells and transduce activation signals through the chimeric receptor to augment CD8+ T cell proliferation, cytokine production and cytotoxic function.